Johnson & Johnson · JNJ
As of the latest run, Johnson & Johnson (JNJ) scores 32/100 overall — a fragile profile across several dimensions. Its strongest dimension: momentum (50/100); the one that most warrants attention: valuation (12/100).
Pillar marked “not applicable” for this profile: growth — typical of financials, whose balance sheet follows its own logic; the overall score is built on the remaining pillars.
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
No pillar clears 60/100 at the latest run: Johnson & Johnson's current profile shows no standout strength according to the engine.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Valuation falls to 12/100 — a stretched price relative to the stock's own valuation history. Financial health falls to 19/100 — a balance sheet under strain, on debt or liquidity. Profitability falls to 38/100 — thin margins or a disappointing return on capital.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.